Physician Profile
Based in Tucson, AZ, Joseph Buscema, M.D. is listed in the NPI registry under gynecologic oncology. Joseph graduated from Johns Hopkins University School of Medicine in 1980. According to Medicare claims data, Joseph cared for 1,008 Medicare patients across 103,864 services. The services billed most often include injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram, injection, paclitaxel, 1 mg, and injection, fosaprepitant, 1 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
603 N WILMOT RD STE 151
Tucson, AZ 85711
103,864 services · 1,008 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Collection of blood sample from implanted device | Procedure | 36591 |
356 | Too few peers to compare |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
1,149 | More than most peers in Gynecologic Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
535 | More than most peers in Gynecologic Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
290 | More than most peers in Gynecologic Oncology |
| Administration of additional new drug or substance into vein, 1 hour or less | Treatment | 96417 |
230 | More than most peers in Gynecologic Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
221 | More often than most peers in Gynecologic Oncology |
| Injection, paclitaxel, 1 mg | Drug given | J9267 |
17,298 | More often than most peers in Gynecologic Oncology |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
16,950 | More than most peers in Gynecologic Oncology |
| Injection, aprepitant, 1 mg | Drug given | J0185 |
11,050 | Too few peers to compare |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
8,675 | Too few peers to compare |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Joseph Buscema is a gynecologic oncology in Tucson, AZ. That is the designation recorded for this NPI in the federal registry.
NPI registry
Joseph Buscema is listed at 603 N Wilmot Rd Ste 151, Tucson, AZ 85711. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (520) 886-0206. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Joseph Buscema's National Provider Identifier is 1891764502. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Joseph Buscema attended Johns Hopkins University School of Medicine, graduating in 1980. This comes from the CMS National Downloadable File.
CMS public data
Joseph Buscema has 46 years experience. Calculated from a graduation year of 1980, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Joseph Buscema performs procedures including collection of blood sample from implanted device; provides treatments such as injection of additional new drug or substance into vein and administration of chemotherapy into vein, 1 hour or less. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Joseph Buscema. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.